|
Clinical Trials and Observations
Citations 191-200 of 2742 total displayed.
|
Past content
(since May 1998):
|
The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group
- Thomas Burmeister, Claus Meyer, Stefan Schwartz, Julia Hofmann, Mara Molkentin, Eric Kowarz, Björn Schneider, Thorsten Raff, Richard Reinhardt, Nicola Gökbuget, Dieter Hoelzer, Eckhard Thiel, and Rolf Marschalek
Blood 2009; 113: 4011-4015.
[Abstract]
[Full text]
[PDF]
Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability
- Cynthia A. Pise-Masison, Michael Radonovich, Kathleen Dohoney, John C. Morris, Deirdre O'Mahony, Min-Jung Lee, Jane Trepel, Thomas A. Waldmann, John E. Janik, and John N. Brady
Blood 2009; 113: 4016-4026.
[Abstract]
[Full text]
[PDF]
Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency
- Bénédicte Neven, Sandrine Leroy, Hélène Decaluwe, Francoise Le Deist, Capucine Picard, Despina Moshous, Nizar Mahlaoui, Marianne Debré, Jean-Laurent Casanova, Liliane Dal Cortivo, Yoann Madec, Salima Hacein-Bey-Abina, Geneviève de Saint Basile, Jean-Pierre de Villartay, Stéphane Blanche, Marina Cavazzana-Calvo, and Alain Fischer
Blood 2009; 113: 4114-4124.
[Abstract]
[Full text]
[PDF]
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005
- Åsa Rangert Derolf, Sigurdur Yngvi Kristinsson, Therese M.-L. Andersson, Ola Landgren, Paul W. Dickman, and Magnus Björkholm
Blood 2009; 113: 3666-3672.
[Abstract]
[Full text]
[PDF]
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
- Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, and Eva Kimby
Blood 2009; 113: 3673-3678.
[Abstract]
[Full text]
[PDF]
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma
- Marie L. De Bruin, Jacobus A. Burgers, Paul Baas, Mars B. van 't Veer, Evert M. Noordijk, Marieke W. J. Louwman, Josée M. Zijlstra, Hendrik van den Berg, Berthe M. P. Aleman, and Flora E. van Leeuwen
Blood 2009; 113: 3679-3681.
[Abstract]
[Full text]
[PDF]
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
- Nathalie A. Johnson, Merrill Boyle, Ali Bashashati, Stephen Leach, Angela Brooks-Wilson, Laurie H. Sehn, Mukesh Chhanabhai, Ryan R. Brinkman, Joseph M. Connors, Andrew P. Weng, and Randy D. Gascoyne
Blood 2009; 113: 3773-3780.
[Abstract]
[Full text]
[PDF]
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab
- Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Alexandra M. Livingstone, Jonathan W. Friedberg, Faith Young, Richard I. Fisher, Raymond J. Kelleher, Jr, Richard B. Bankert, and Steven H. Bernstein
Blood 2009; 113: 3809-3812.
[Abstract]
[Full text]
[PDF]
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
- Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno, Giorgina Specchia, Piero Galieni, Franco Iuliano, Fabrizio Pane, Giuseppe Saglio, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti, and for the GIMEMA CML Working Party
Blood 2009; 113: 3428-3434.
[Abstract]
[Full text]
[PDF]
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
- Heinz Ludwig, Roman Hajek, Elena Tóthová, Johannes Drach, Zdenek Adam, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Richard Greil, Ingrid Kuhn, Niklas Zojer, and Axel Hinke
Blood 2009; 113: 3435-3442.
[Abstract]
[Full text]
[PDF]
|
|
